Recombinant human IgE antibody (hIgEλ), whose amino acid sequences are identical to the first-described IgE antibody from a myeloma patient with initials N.D. The recombinant antibody is produced transiently under serum-free conditions in optimized HEK293-cell system and purified through one-step purification with affinity chromatography.
